Wall Street Analysts Believe Sagimet Biosciences Inc. (SGMT) Could Rally 298.5%: Here's is How to Trade

Analysts' mean price target for Sagimet Biosciences (SGMT) implies 298.5% upside, signaling bullish expectations for the stock. The article also notes broad agreement in raising earnings estimates, which supports the positive outlook. The piece is largely analyst commentary rather than a new company-specific catalyst.

Analysis

Analysts' mean price target for Sagimet Biosciences (SGMT) implies 298.5% upside, signaling bullish expectations for the stock. The article also notes broad agreement in raising earnings estimates, which supports the positive outlook. The piece is largely analyst commentary rather than a new company-specific catalyst.